Adaptive Biotechnologies Corporation

Add to watchlist
€29.2
Last updated:06/09/2021
1HM: F
Adaptive Biotechnologies Corporation

Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer translational research questions, as well as to dis… Show more

P/E ratio
-

Stock volatility (Beta)
past 12 months

Become our supporter to unlock all data!
Company results
Quarterly
Annual
Fundamentals
2017
2018
2019
2020
Net Income
Income minus expenses, depreciation, interest, taxes, and other expenses
-42.831M
-46.447M
-8.44%
-68.606M
-47.71%
-146.227M
-113.14%
Cashflow
Sum up money going in and out company
-34.858M
-32.259M
+7.46%
205.404M
+736.73%
-149.683M
-172.87%
Total liabilities
All combined debts and obligations
587.105M
590.8M
+0.63%
341.263M
-42.24%
373.148M
+9.34%
Company profile
CEO
Mr. Chad M. Robins M.B.A., M.B.A
Market capitalization
Mid (4.01B)